The present invention provides a method for detecting or predicting ischemic disorders in a subject by using as an indication the concentration of human lipocalin-type prostaglandin D synthase (hPGDS) in body fluid samples from the subject. More specifically, the method comprises comparing the hPGDS concentrations in the body fluid samples from a subject with the reference values established for a normal subject, thereby detecting or predicting the ischemic disorders.
本发明提供了一种检测或预测受试者缺血性疾病的方法,该方法使用受试者体液样本中人脂
钙素型
前列腺素 D 合酶(h
PGDS)的浓度作为指标。更具体地说,该方法包括将受试者体液样本中的 h
PGDS 浓度与为正常受试者确定的参考值进行比较,从而检测或预测缺血性疾病。